Search

Author/Creator Yahya, Sundus

2. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

Authors:
Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma...
Journal:
Lancet
Issue:
Volume 393:Issue 10191(2019)
Page Start:
2599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ultrahypofractionated breast radiotherapy during SARS-CoV-2 virus pandemic, beyond fast-forward trial: a local experience. (20th January 2023)

Authors:
Yahya, Sundus; Fatima, Tamseel; Irwin, Amy Louise; Clayton, Melanie; Spooner, David; Fernando, Indrajit; Stevens, Andrea; Sherriff, Jenny; Henderson, Daniel
Journal:
Journal of radiotherapy in practice
Issue:
Volume 22(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗